Rimidi & Eli Lilly Form Agreement To Personalize Solutions For Consumers Using Insulin

Rimidi and Eli Lilly and Company (Eli Lilly) have agreed to work together to develop provider-based tools that integrate personalized solutions for consumers with diabetes who use insulin. This will be accomplished by integrating Eli Lilly’s developing integrated insulin management system with Rimidi’s software platform for diabetes management.

It is anticipated that these efforts will help ease the difficulty of diabetes management for the 30 million Americans who live with the disease. Additionally, the two companies hope to assist providers in coordinating clinical workflow with their patients’ insulin use regimens.

Rimidi is a digital health company that . . .